GSK3 inhibitors enhance retinoic acid receptor activity and induce the differentiation of retinoic acid-sensitive myeloid leukemia cells

Leukemia

Volumn 25, Issue 12, 2011, Pages 1914-1918

  Si, J ^a   Mueller, L ^a   Collins, S J ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; 2 (3 CHLORO 4 HYDROXYANILINO) 3 (2 NITROPHENYL)MALEIMIDE; AR A014418; CT 99021; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CONSENSUS SEQUENCE; DRUG MECHANISM; ENZYME SUBSTRATE; HUMAN; LETTER; LEUKEMIA CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION;

BLOTTING, WESTERN; CELL DIFFERENTIATION; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LEUKEMIA, MYELOID; PHOSPHORYLATION; RECEPTORS, RETINOIC ACID; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 83555173376     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.171     Document Type: Letter

References (8)

1. Embi N, Rylatt DB, Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 1980; 107: 519-527.
2. Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J 2001; 359: 1-16. (Pubitemid 32939202)
3. Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008; 8: 83-93. (Pubitemid 351161321)
4. Ghosh JC, Altieri DC. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells. Clin Cancer Res 2005; 11: 4580-4588. (Pubitemid 40825649)
5. Wang Z, Smith KS, Murphy M, Piloto O, Somervaille TC, Cleary ML. Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy. Nature 2008; 455: 1205-1209.
6. Si J, Mueller L, Collins SJ. CaMKII regulates retinoic acid receptor transcriptional activity and the differentiation of myeloid leukemia cells. J Clin Invest 2007; 117: 1412-1421. (Pubitemid 46718429)
7. Cohen P, Goedert M. GSK3 inhibitors: development and therapeutic potential. Nat Rev Drug Discov 2004; 3: 479-487. (Pubitemid 38807530)
8. Giacobini E, Becker RE. One hundred years after the discovery of Alzheimer's disease. A turning point for therapy? J Alzheimers Dis 2007; 12: 37-52. (Pubitemid 47396306)